Drug
Icp 490
Icp 490: highest development phase Phase 1/2, developed by InnoCare Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- InnoCare Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| ICP-490 NCT06845241 | Phase 1/2 | Relapsed or Refractory Non-Hodgkin Lymphoma |
Latest
No recent events.
Follow Icp 490 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.